RAMUCIRUMAB

UNII:	D99YVK4L0X
Formula:
Preferred Substance Name:	RAMUCIRUMAB

947687-13-0
1121B
CYRAMZA
IMC-1121B
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
LY3009806
RAMUCIRUMAB [INN]
RAMUCIRUMAB [JAN]
RAMUCIRUMAB [MART.]
RAMUCIRUMAB [MI]
RAMUCIRUMAB [PURPLE BOOK CDER]
RAMUCIRUMAB [USAN]
RAMUCIRUMAB [VANDF]
RAMUCIRUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RAMUCIRUMAB

Synonyms and Mappings

Resources